3 Value Dividend Stocks You Don’t Know Are High Yield

Investing surprises can be good or bad. The CEO negotiates a sale of the company at a 50% premium to the current market price is good. The CEO is… Read more

Why More Companies Should Follow Apple’s Lead

A year ago, the largest stock in the world was in freefall. After hitting an all-time high of $700 in September 2012, Apple (Nasdaq: AAPL) shares tanked for more… Read more

Is it Time to Rescue this Dividend Dog?

They’re called dividend dogs. These are companies the markets hate – yet deliver attractive dividend income and give us the opportunity for a significant stock price increase as well…. Read more

The Four Best Dividend Stocks to Buy in August

The walls around this powerful bull market are starting to show some cracks. The S&P 500 has declined nearly 3% in the past month, most of which has come… Read more

If You Don’t Know the ‘9th Wonder’ of Investing, You Don’t Know What You’re Missing

Many of you are familiar with the seven wonders of the world – seven remarkable constructions of classical antiquity. Of the original seven, only one – The Great Pyramid… Read more

Top 3 Dividends In This Emerging Market

Brazil, despite its somewhat sluggish economy, has been a big winner in the stock market. The iShares MSCI Brazil Index is up nearly 29% over the last six month…. Read more

This One Cut Can Kill Your Investment Returns

As the dividend goes, so too goes the share price. For this reason, I’m attracted to quality dividend-growth stocks. Look no further than dividend-growth powerhouses ExxonMobil (NYSE: XOM), Altria… Read more

3 Dividend Yielding International Stocks

Don’t let the word “international” scare you. In any non-retirement long-term diversified portfolio, I think international stocks should have something like 10-15% of your dollars.  Yet investors have a… Read more

Wyatt Research Week-in-Review: July 27-August 2

It’s been a busy week here at Wyatt Investment Research. We’ve covered everything from the trouble – and rewards – of IPOs to biotechs to opportunity in Russia. Meantime,… Read more

To top